Literature DB >> 17226818

Versican proteolysis mediates myocardial regression during outflow tract development.

Christine B Kern1, Russell A Norris, Robert P Thompson, W Scott Argraves, Sarah E Fairey, Leticia Reyes, Stanley Hoffman, Roger R Markwald, Corey H Mjaatvedt.   

Abstract

An important phase of cardiac outflow tract (OFT) formation is the remodeling of the distal region of the common outlet in which the myocardial sleeve is replaced by with smooth muscle. Here we demonstrate that expression of the proteoglycan versican is reduced before the loss of myocardium from the distal cardiac outlet concomitant with an increase in production of the N-terminal cleavage fragment of versican. To test whether versican proteolysis plays a role in OFT remodeling, we determined the effects of adenoviral-mediated expression of a versican isoform devoid of known matrix metalloproteinase cleavage sites (V3) and an N-terminal fragment of versican (G1). V3 expression promoted an increase in thickness of the proximal OFT myocardial layer independent of proliferation. In contrast, the G1 domain caused thinning and interruptions of the OFT myocardium. These in vivo findings were consistent with findings using cultured primary cardiomyocytes showing that the V3 promoted myocardial cell-cell association while the G1 domain caused a loss of myocardial cell-cell association. Taken together, we conclude that intact versican and G1-containing versican cleavage products have opposing effects on myocardial cells and that versican proteolysis may facilitate the loss of distal myocardium during OFT remodeling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17226818      PMCID: PMC1828600          DOI: 10.1002/dvdy.21059

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  53 in total

1.  A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors.

Authors:  H Mizuguchi; M A Kay
Journal:  Hum Gene Ther       Date:  1999-08-10       Impact factor: 5.695

2.  Myocardialization of the cardiac outflow tract.

Authors:  M J van den Hoff; A F Moorman; J M Ruijter; W H Lamers; R W Bennington; R R Markwald; A Wessels
Journal:  Dev Biol       Date:  1999-08-15       Impact factor: 3.582

3.  Proteolytic cleavage of versican during cardiac cushion morphogenesis.

Authors:  Christine B Kern; Waleed O Twal; Corey H Mjaatvedt; Sarah E Fairey; Bryan P Toole; M Luisa Iruela-Arispe; W Scott Argraves
Journal:  Dev Dyn       Date:  2006-08       Impact factor: 3.780

4.  The sensitivity of versican from rabbit lung to gelatinase A (MMP-2) and B (MMP-9) and its involvement in the development of hydraulic lung edema.

Authors:  A Passi; D Negrini; R Albertini; G Miserocchi; G De Luca
Journal:  FEBS Lett       Date:  1999-07-30       Impact factor: 4.124

Review 5.  The interaction of versican with its binding partners.

Authors:  Yao Jiong Wu; David P La Pierre; Jin Wu; Albert J Yee; Burton B Yang
Journal:  Cell Res       Date:  2005-07       Impact factor: 25.617

6.  Adamts9 is widely expressed during mouse embryo development.

Authors:  Katherine A Jungers; Carine Le Goff; Robert P T Somerville; Suneel S Apte
Journal:  Gene Expr Patterns       Date:  2005-04-20       Impact factor: 1.224

7.  Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican.

Authors:  A Aspberg; S Adam; G Kostka; R Timpl; D Heinegård
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

8.  Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain.

Authors:  L C Ang; Y Zhang; L Cao; B L Yang; B Young; C Kiani; V Lee; K Allan; B B Yang
Journal:  J Neuropathol Exp Neurol       Date:  1999-06       Impact factor: 3.685

9.  Confocal imaging of the embryonic heart: how deep?

Authors:  Christine E Miller; Robert P Thompson; Michael R Bigelow; George Gittinger; Thomas C Trusk; David Sedmera
Journal:  Microsc Microanal       Date:  2005-06       Impact factor: 4.127

10.  Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1.

Authors:  Nathan V Lee; Juan Carlos Rodriguez-Manzaneque; Shelley N-M Thai; Waleed O Twal; Alfonso Luque; Karen M Lyons; W Scott Argraves; M Luisa Iruela-Arispe
Journal:  J Biol Chem       Date:  2005-08-01       Impact factor: 5.157

View more
  46 in total

1.  Anatomical correlates relevant to ablation above the semilunar valves for the cardiac electrophysiologist: a study of 603 hearts.

Authors:  Apoor S Gami; Amit Noheria; Nirusha Lachman; William D Edwards; Paul A Friedman; Deepak Talreja; Stephen C Hammill; Thomas M Munger; Douglas L Packer; Samuel J Asirvatham
Journal:  J Interv Card Electrophysiol       Date:  2010-12-15       Impact factor: 1.900

2.  The ADAMTS1 protease gene is required for mammary tumor growth and metastasis.

Authors:  Carmela Ricciardelli; Kate M Frewin; Izza de Arao Tan; Elizabeth D Williams; Kenneth Opeskin; Melanie A Pritchard; Wendy V Ingman; Darryl L Russell
Journal:  Am J Pathol       Date:  2011-10-12       Impact factor: 4.307

3.  A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophy.

Authors:  Richard D Kenagy; Seung-Kee Min; Eileen Mulvihill; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2011-04-14       Impact factor: 4.268

4.  Cooperation of two ADAMTS metalloproteases in closure of the mouse palate identifies a requirement for versican proteolysis in regulating palatal mesenchyme proliferation.

Authors:  Hiroyuki Enomoto; Courtney M Nelson; Robert P T Somerville; Katrina Mielke; Laura J Dixon; Kimerly Powell; Suneel S Apte
Journal:  Development       Date:  2010-11-01       Impact factor: 6.868

5.  Adamts5-/- Mice Exhibit Altered Aggrecan Proteolytic Profiles That Correlate With Ascending Aortic Anomalies.

Authors:  Loren E Dupuis; E Lockett Nelson; Brittany Hozik; Sarah C Porto; Alexandra Rogers-DeCotes; Amanda Fosang; Christine B Kern
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-01       Impact factor: 8.311

6.  Expression of V3 Versican by Rat Arterial Smooth Muscle Cells Promotes Differentiated and Anti-inflammatory Phenotypes.

Authors:  Inkyung Kang; Jeremy L Barth; Erin P Sproul; Dong Won Yoon; Gail A Workman; Kathleen R Braun; W Scott Argraves; Thomas N Wight
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

7.  Correlation of Versican Expression, Accumulation, and Degradation during Embryonic Development by Quantitative Immunohistochemistry.

Authors:  Jessica M Snyder; Ida M Washington; Timothy Birkland; Mary Y Chang; Charles W Frevert
Journal:  J Histochem Cytochem       Date:  2015-09-18       Impact factor: 2.479

8.  Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome.

Authors:  Jennifer J Hofmann; Anais Briot; Josephine Enciso; Ann C Zovein; Shuxun Ren; Zhen W Zhang; Freddy Radtke; Michael Simons; Yibin Wang; M Luisa Iruela-Arispe
Journal:  Development       Date:  2012-10-24       Impact factor: 6.868

9.  Insufficient versican cleavage and Smad2 phosphorylation results in bicuspid aortic and pulmonary valves.

Authors:  Loren E Dupuis; Hanna Osinska; Michael B Weinstein; Robert B Hinton; Christine B Kern
Journal:  J Mol Cell Cardiol       Date:  2013-03-24       Impact factor: 5.000

10.  Cartilage link protein 1 (Crtl1), an extracellular matrix component playing an important role in heart development.

Authors:  Elaine E Wirrig; Brian S Snarr; Mastan R Chintalapudi; Jessica L O'neal; Aimee L Phelps; Jeremy L Barth; Victor M Fresco; Christine B Kern; Corey H Mjaatvedt; Bryan P Toole; Stanley Hoffman; Thomas C Trusk; W Scott Argraves; Andy Wessels
Journal:  Dev Biol       Date:  2007-08-09       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.